NasdaqCM - Nasdaq Real Time Price USD
Aligos Therapeutics, Inc. (ALGS)
5.83
+0.47
+(8.77%)
At close: April 24 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -2.97 | -3.1 | -8.65 | -12.96 |
| Low Estimate | -3.57 | -3.85 | -15.99 | -16.95 |
| High Estimate | -2.37 | -2.35 | -1.31 | -8.97 |
| Year Ago EPS | -5.5 | 0.75 | -20.94 | -8.65 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | 333.33k | 333.33k | 26.33M | 1.33M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | 1M | 1M | 75M | 4M |
| Year Ago Sales | 986k | 1.06M | 3.94M | 26.33M |
| Sales Growth (year/est) | -66.19% | -68.58% | 567.51% | -94.94% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -4.75 | -4 | -1.33 | -3.67 |
| EPS Actual | -5.5 | 0.75 | -3.07 | -13.1 |
| Difference | -0.75 | 4.75 | -1.74 | -9.43 |
| Surprise % | -15.79% | 118.75% | -131.70% | -256.95% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.97 | -3.1 | -8.65 | -12.96 |
| 7 Days Ago | -3.04 | -3.28 | -13.01 | -13.14 |
| 30 Days Ago | -3.04 | -3.28 | -13.01 | -13.14 |
| 60 Days Ago | -3.04 | -3.28 | -13.01 | -13.14 |
| 90 Days Ago | -3.04 | -3.28 | -13.01 | -13.14 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 2 | 1 |
| Up Last 30 Days | 1 | 1 | 2 | 1 |
| Down Last 7 Days | 1 | 1 | -- | 1 |
| Down Last 30 Days | 1 | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ALGS | 46.00% | -513.33% | 58.69% | -49.83% |
| S&P 500 | 6.94% | 4.52% | 8.32% | 14.18% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/31/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/7/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 10/23/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 9/20/2024 |
| Initiated | HC Wainwright & Co.: Buy | 8/19/2024 |
Related Tickers
CLDI Calidi Biotherapeutics, Inc.
0.4973
+3.58%
RVPH Reviva Pharmaceuticals Holdings, Inc.
0.9000
+4.32%
SGMT Sagimet Biosciences Inc.
3.1200
+12.43%
ASMB Assembly Biosciences, Inc.
10.53
+1.15%
GLTO Galecto, Inc.
2.8500
+3.64%
BIVI BioVie Inc.
0.8941
+6.42%
TIL Instil Bio, Inc.
19.61
-4.43%
HLVX HilleVax, Inc.
1.8500
-0.54%
SPRO Spero Therapeutics, Inc.
0.7250
-0.29%
ANTX AN2 Therapeutics, Inc.
1.2900
+1.57%